Ginkgo biloba in the management of the COVID-19 severity
Article
[키워드] acute lung injury
acute respiratory distress
acute respiratory syndrome
aggregation
alleviate
Anti-inflammatory
antioxidant
Antiviral
Antiviral effect
attenuate
booster
complementary
complementary medicine
complications
coronavirus disease
Coronavirus-2
COVID-19
COVID-19 severity
Critical
drug
Effect
Effectiveness
extreme
Ginkgo
Ginkgo biloba
impede
Infection
inflammatory disorder
management
mechanisms
nanomedicines
Neutrophil elastase
offer
oxidative stress
Platelet
proinflammatory cytokines
protease
Proteases
provide
SARS-CoV-2
symptomatic
syndrome
therapy
thrombosis
viral proteases
[DOI] 10.1002/ardp.202200188 PMC 바로가기
[DOI] 10.1002/ardp.202200188 PMC 바로가기